Patents by Inventor John H. Heiligenstein

John H. Heiligenstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of attention-deficit/hyperactivity disorder
    Patent number: 5658590
    Abstract: Tomoxetine, a norepinephrine uptake inhibitor, is used to treat attention-deficit/hyperactivity disorder.
    Type: Grant
    Filed: January 11, 1995
    Date of Patent: August 19, 1997
    Assignee: Eli Lilly and Company
    Inventors: John H. Heiligenstein, Gary D. Tollefson